A Study of FL115 in Combination With a PD-1 Antibody in Advanced Solid Tumors

NCT07131202 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: FL115+PD-1

Sponsor

Suzhou Forlong Biotechnology Co., Ltd